MBC issues correction over Ursa

The broadcaster MBC on Wednesday issued the correction over Daewoong Pharm’s Ursa, thehe best-selling hepatic function medicine, denying that Ursa is nearly similar to a digestive, not a drug to combat fatigue, which was raised by a civic group on Sept. 7.

In its Wednesday evening news, MBC said Ursa is a prescription drug for the improved of hepatic function in chronic liver disease, system...